Epidemiology, etiology, and diagnosis of osteoporosis.
暂无分享,去创建一个
[1] T. Abbott,et al. Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] J. Kanis,et al. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report , 1994, Osteoporosis International.
[3] O. Johnell,et al. Mortality after osteoporotic fractures , 2004, Osteoporosis International.
[4] O. Johnell,et al. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures , 1996 .
[5] Dennis M. Black,et al. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy , 2002 .
[6] N. Watts,et al. Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: A two-year study , 2000, Menopause.
[7] R. Eastell,et al. The Use of Biochemical Markers of Bone Turnover in Osteoporosis , 2000, Osteoporosis International.
[8] J. Compston. Bone density: BMC, BMD, or corrected BMD? , 1995, Bone.
[9] Richard Eastell,et al. Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. , 2004, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[10] K. Baek,et al. Official Positions of the International Society for Clinical Densitometry. , 2005 .
[11] T. O’Neill. The Relationship Between Bone Density and Incident Vertebral Fracture in Men and Women , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[12] Fran Harris,et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. , 2002, The American journal of medicine.
[13] P Burckhardt,et al. [Epidemiology of osteoporosis]. , 1997, Schweizerische medizinische Wochenschrift.
[14] P Geusens,et al. Risk of new vertebral fracture in the year following a fracture. , 2001, JAMA.
[15] S. Cummings,et al. Endogenous Hormones and the Risk of Hip and Vertebral Fractures Among Older Women , 1999 .
[16] Jing Fang,et al. Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City. , 2004, Ethnicity & disease.
[17] Sharmila Majumdar,et al. Osteoporosis imaging. , 2003, Radiologic clinics of North America.
[18] S. Cummings,et al. Body Size and Hip Fracture Risk in Older Women: A Prospective Study , 1997 .
[19] P. Delmas,et al. Biochemical markers of bone turnover , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] S. Boonen,et al. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. , 2005, Clinical therapeutics.
[21] A. Chines,et al. Effect of Combined Risedronate and Hormone Replacement Therapies on Bone Mineral Density in Postmenopausal Women , 2001 .
[22] S. Cummings,et al. Body size and hip fracture risk in older women: a prospective study. Study of Osteoporotic Fractures Research Group. , 1997, The American journal of medicine.
[23] Laura B. Hansen,et al. Current approaches to the prevention and treatment of postmenopausal osteoporosis. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[24] O. Johnell,et al. Quality of Life in Patients with Vertebral Fractures: Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) , 1999, Osteoporosis International.
[25] B. Dawson-Hughes,et al. Smoking increases bone loss and decreases intestinal calcium absorption. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] C. Christiansen,et al. Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[27] M. Mezey,et al. Differences in outcome between black and white elderly hip fracture patients. , 1987, Journal of chronic diseases.
[28] C. Cooper,et al. Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience. , 2003, Bone.
[29] P. Delmas,et al. Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: the OFELY study. , 2003, Bone.
[30] P. Lips,et al. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. , 2001, Endocrine reviews.
[31] J. Peipert,et al. Screening for Osteoporosis in Postmenopausal Women: Recommendations and Rationale , 2002, Annals of Internal Medicine.
[32] E. Barrett-Connor,et al. Prediction of Fracture Risk in Postmenopausal White Women With Peripheral Bone Densitometry: Evidence From the National Osteoporosis Risk Assessment , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[33] Ego Seeman,et al. The structural and biomechanical basis of the gain and loss of bone strength in women and men. , 2003, Endocrinology and metabolism clinics of North America.
[34] Harry K. Genant,et al. Interim Report and Recommendations of the World Health Organization Task-Force for Osteoporosis , 1999, Osteoporosis International.
[35] C. Cooper,et al. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. , 2003, Arthritis and rheumatism.
[36] O. Johnell,et al. Epidemiology of osteoporotic fractures , 2005, Osteoporosis International.
[37] M. Law,et al. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect , 1997, BMJ.
[38] J. Eisman,et al. Osteoporosis in Elderly Men and Women: Effects of Dietary Calcium, Physical Activity, and Body Mass Index , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] S. Christakos,et al. Primer on the metabolic bone diseases and disorders of mineral metabolism , 1994 .
[40] S. Cummings,et al. Bone density at various sites for prediction of hip fractures , 1993, The Lancet.
[41] R. Eastell,et al. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. , 1995, Annals of the rheumatic diseases.
[42] P. Delmas,et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] P. Miller. Management of osteoporosis. , 1999, Disease-a-month : DM.
[44] J Pearson,et al. Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[45] B. Lawrence Riggs,et al. Osteoporosis : etiology, diagnosis, and management , 1988 .
[46] Rees,et al. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. , 1995, Clinical chemistry.
[47] D. Kiel,et al. Risk Factors for Longitudinal Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[48] S. Cummings,et al. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. , 1998, The New England journal of medicine.
[49] R. Eastell,et al. Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[50] S. Cummings,et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.
[51] M. Seibel. Biochemical markers of bone remodeling. , 2003, Endocrinology and metabolism clinics of North America.
[52] M. Seibel,et al. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. , 2001, Clinical chemistry.
[53] O. Johnell,et al. An Assessment Tool for Predicting Fracture Risk in Postmenopausal Women , 2001, Osteoporosis International.
[54] J. Brody,et al. Sex-specific and race-specific hip fracture rates. , 1990, American journal of public health.
[55] Susan R. Johnson,et al. Osteoporosis prevention, diagnosis, and therapy. , 2001, JAMA.
[56] S. Cummings,et al. Epidemiology and outcomes of osteoporotic fractures , 2002, The Lancet.
[57] S. Manolagas,et al. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.
[58] H. Rodbard,et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. , 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[59] E. Itoi,et al. Impact of postural deformities and spinal mobility on quality of life in postmenopausal osteoporosis , 2003, Osteoporosis International.
[60] D. Shelton,et al. Radiologic bone assessment in the evaluation of osteoporosis. , 2002, American family physician.
[61] R. Recker,et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS: 2001 EDITION, WITH SELECTED UPDATES FOR 2003* AACE Osteoporosis Task Force Chairmen , 2003 .
[62] V. Gilsanz,et al. Establishment of peak bone mass. , 2003, Endocrinology and metabolism clinics of North America.
[63] S. Sun,et al. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. , 2001, Clinical chemistry.
[64] Jacques P. Brown,et al. The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women , 2002, BMC musculoskeletal disorders.
[65] J. Bigby. Harrison's Principles of Internal Medicine , 1988 .
[66] P. Miller,et al. Discordance in patient classification using T-scores. , 1999, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[67] Volker Kuhn,et al. Can Novel Clinical Densitometric Techniques Replace or Improve DXA in Predicting Bone Strength in Osteoporosis at the Hip and Other Skeletal Sites? , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[68] K. Usadel,et al. Validation of a new automated immunoassay for measurement of intact osteocalcin. , 2002, Clinical laboratory.
[69] Anders Isaksson,et al. Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.